share_log

Recursion Pharmaceuticals | 144/A: Others

Recursion Pharmaceuticals | 144/A: Others

Recursion Pharmaceuticals | 144/A:其他
美股SEC公告 ·  06/14 17:16
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/14/2024, as per the latest filing. The shares, valued at an aggregate market value of $139,081.62, were originally acquired on 06/13/2023 through a stock option exercise from the issuer, with payment made in cash on the same date. This planned transaction follows a series of sales over the past three months, where a total of 63,124 shares were sold for gross proceeds of $506,805.72.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/14/2024, as per the latest filing. The shares, valued at an aggregate market value of $139,081.62, were originally acquired on 06/13/2023 through a stock option exercise from the issuer, with payment made in cash on the same date. This planned transaction follows a series of sales over the past three months, where a total of 63,124 shares were sold for gross proceeds of $506,805.72.
Recursion Pharmaceuticals, Inc.執行官Secora Michael計劃於2024年06月14日賣出15,000股A類股份,根據最新的文件。這些股票價值總市值爲139,081.62美元,最初於2023年06月13日通過股票期權行權從發行人收購,當日以現金方式付款。這項計劃的交易跟隨了過去三個月的一系列銷售,共賣出63,124股,總收益爲506,805.72美元。
Recursion Pharmaceuticals, Inc.執行官Secora Michael計劃於2024年06月14日賣出15,000股A類股份,根據最新的文件。這些股票價值總市值爲139,081.62美元,最初於2023年06月13日通過股票期權行權從發行人收購,當日以現金方式付款。這項計劃的交易跟隨了過去三個月的一系列銷售,共賣出63,124股,總收益爲506,805.72美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息